IMI2-2018-16-02
IMI2-2018-16-02
1 project · €5,687,984 total EU contribution (project-level) · 10 participating organizations · 6 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€5,687,984
Countries active
Participant organizations by country (headquarters in CORDIS).
- Netherlands (3)
- BE (2)
- France (2)
- AT (1)
- CH (1)
- DK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- Leiden University Medical Center1 projects · NL
- BVS1 projects · CH
- FFUND BV1 projects · NL
- JANSSEN PHARMACEUTICA NV1 projects · BE
- UCPH1 projects · DK
- MEDIZINISCHE UNIVERSITAET WIEN1 projects · AT
- MITOLOGICS1 projects · FR
- SORBONNE UNIVERSITE1 projects · FR
- UANTWERPEN1 projects · BE
- ULEI1 projects · NL
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline RespiriNTM · 853932 | H2020 | €5,687,984 | €795,500 | Details |